Cystic fibrosis therapy: A community ecology perspective

American Journal of Respiratory Cell and Molecular Biology

Volumn 48, Issue 2, 2013, Pages 150-156

  Conrad, Douglas ^a   Haynes, Matthew ^b   Salamon, Peter ^c   Rainey, Paul B ^d,e   Youle, Merry ^f   Rohwer, Forest ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DOE JOINT GENOME INSTITUTE   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d MASSEY UNIVERSITY   (New Zealand)

^e MAX PLANCK INSTITUTE FOR EVOLUTIONARY BIOLOGY   (Germany)

^f Rainbow Rock   (United States)

Author keywords

Airway ecology; Cystic fibrosis; Metagenomics

Indexed keywords

ACHROMOBACTER; ANTIBIOTIC THERAPY; ASPERGILLUS; BURKHOLDERIA CEPACIA COMPLEX; CANDIDA; CLINICAL PROTOCOL; COMMUNITY ECOLOGY; CYSTIC FIBROSIS; DISEASE COURSE; HAEMOPHILUS INFLUENZAE; HUMAN; INNATE IMMUNITY; LUNG; MATHEMATICAL MODEL; METAGENOME; METAGENOMICS; MICROBIAL POPULATION DYNAMICS; MICROENVIRONMENT; MICROFLORA; MYCOBACTERIUM; NONHUMAN; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; REVIEW; SCEDOSPORIUM; SIMULATION; STAPHYLOCOCCUS AUREUS; STATISTICAL MODEL; STENOTROPHOMONAS MALTOPHILIA; TAXONOMY;

ANTI-BACTERIAL AGENTS; BACTERIA; CYSTIC FIBROSIS; HUMANS;

EID: 84873372370     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0059PS     Document Type: Review

References (59)

1. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Bruce KD. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 2004;42: 5176-5183.
2. Willner D, Furlan M, Haynes M, Schmieder R, Angly FE, Silva J, Tammadoni S, Nosrat B, Conrad D, Rohwer F. Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals. PLoS ONE 2009;4:e7370.
3. van der Gast CJ, Walker AW, Stressmann FA, Rogers GB, Scott P, Daniels TW, Carroll MP, Parkhill J, Bruce KD. Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities. ISME J 2011;5:780-791.
4. Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology 2007;153:917-923.
5. Klepac-Ceraj V, Lemon KP, Martin TR, Allgaier M, Kembel SW, Knapp AA, Lory S, Brodie EL, Lynch SV, Bohannan BJ, et al. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol 2010;12:1293-1303.
6. Rodriguez-Brito B, Li L, Wegley L, Furlan M, Angly F, Breitbart M, Buchanan J, Desnues C, Dinsdale E, Edwards R, et al. Viral and microbial community dynamics in four aquatic environments. ISME J 2010;4:739-751.
7. Rodriguez-Valera F, Martin-Cuadrado AB, Rodriguez-Brito B, Pasic L, Thingstad TF, Rohwer F, Mira A. Explaining microbial population genomics through phage predation. Nat Rev Microbiol 2009;7:828-836.
8. Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010;23:299-323.
9. Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008;177:995-1001.
10. Ziedalski TM, Kao PN, Henig NR, Jacobs SS, Ruoss SJ. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest 2006;130:995-1002.
11. Forslow U, Geborek A, Hjelte L, Petrini B, Heurlin N. Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis. Acta Paediatr Scand 2003;92:910-915.
12. Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, et al. Nontuberculous mycobacteria: I. Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003;167:828-834.
13. Olivier KN. The natural history of nontuberculous mycobacteria in patients with cystic fibrosis. Paediatr Respir Rev 2004;5 (Suppl. A):S213-216.
14. Marshall B, Hazel L. Cystic Fibrosis Foundation registry report: annual data report. Bethesda, MD: Cystic Fibrosis Foundation; 2010.
15. Willner D, Haynes MR, Furlan M, Hanson N, Kirby B, Lim YW, Rainey PB, Schmieder R, Youle M, Conrad D, et al. Case studies of the spatial heterogeneity of DNA viruses in the cystic fibrosis lung. Am J Respir Cell Mol Biol 2012;46:127-131.
16. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U, Andersen GL, Brown R, Fujimura KE, et al. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS ONE 2010;5:e11044.
17. Harris JK, De Groote MA, Sagel SD, Zemanick ET, Kapsner R, Penvari C, Kaess H, Deterding RR, Accurso FJ, Pace NR. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci USA 2007;104:20529-20533.
18. Willner D, Haynes MR, Furlan M, Schmieder R, Lim YW, Rainey PB, Rohwer F, Conrad D. Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J 2012;6:471-474.
19. Rainey PB, Buckling A, Kassen R, Travisano M. The emergence and maintenance of diversity: insights from experimental bacterial populations. Trends Ecol Evol 2000;15:243-247.
20. Lennon JT, Martiny JB. Rapid evolution buffers ecosystem impacts of viruses in a microbial food web. Ecol Lett 2008;11:1178-1188.
21. Goerke C, Wolz C. Regulatory and genomic plasticity of Staphylococcus aureus during persistent colonization and infection. Int J Med Microbiol 2004;294:195-202.
22. Hanlon GW, Denyer SP, Olliff CJ, Ibrahim LJ. Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2001;67: 2746-2753.
23. Iacocca VF, Sibinga M, Barbero GJ. Respiratory tract bacteriology in cystic fibrosis. Am J Dis Child 1963;106:315-324.
24. Ojeniyi B. Bacteriophages in sputum of cystic fibrosis patients as a possible cause of in vivo changes in serotypes of Pseudomonas aerugi-nosa. APMIS 1988;96:294-298.
25. Sekaninova G, Kolarova M, Pillich J, Semenka J, Slavikova H, Kubickova D, Zajicova V. Pseudomonas aeruginosa phage lysate as an immunobiological agent: 1. Selection of Pseudomonas aeruginosa clinical strains for phage lysate preparation. Folia Microbiol (Praha) 1999;44:93-97.
26. Carmody LA, Gill JJ, Summer EJ, Sajjan US, Gonzalez CF, Young RF, LiPuma JJ. Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection. J Infect Dis 2010;201:264-271.
27. Son MS, Matthews WJ Jr, Kang Y, Nguyen DT, Hoang TT. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect Immun 2007;75: 5313-5324.
28. MacLean RC, Bell G. Experimental adaptive radiation in Pseudomonas. Am Nat 2002;160:569-581.
29. Rainey PB, Travisano M. Adaptive radiation in a heterogeneous environment. Nature 1998;394:69-72.
30. Marozkina NV, Gaston B. Nitrogen balance in the ecosystem of the cystic fibrosis lung. Am J Respir Crit Care Med 2011;183:1290-1292.
31. Schluter D. The ecology of adaptive radiation. Oxford: Oxford University Press; 2000.
32. Nguyen D, Singh PK. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc Natl Acad Sci USA 2006;103:8305-8306.
33. Sutherland IW, Hughes KA, Skillman LC, Tait K. The interaction of phage and biofilms. FEMS Microbiol Lett 2004;232:1-6.
34. Torsvik V, Ovreas L, Thingstad TF. Prokaryotic diversity: magnitude, dynamics, and controlling factors. Science 2002;296:1064-1066.
35. Wommack KE, Ravel J, Hill RT, Chun J, Colwell RR. Population dynamics of Chesapeake Bay virioplankton: total-community analysis by pulsed-field gel electrophoresis. Appl Environ Microbiol 1999;65:231-240.
36. Hansen SK, Rainey PB, Haagensen JA, Molin S. Evolution of species interactions in a biofilm community. Nature 2007;445:533-536.
37. Hoffman LR, Deziel E, D'Argenio DA, Lepine F, Emerson J, McNamara S, Gibson RL, Ramsey BW, Miller SI. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 2006;103:19890-19895.
38. Duerkop BA, Ulrich RL, Greenberg EP. Octanoyl-homoserine lactone is the cognate signal for Burkholderia mallei BmaR1-BmaI1 quorum sensing. J Bacteriol 2007;189:5034-5040.
39. Yang L, Jelsbak L, Marvig RL, Damkiaer S, Workman CT, Rau MH, Hansen SK, Folkesson A, Johansen HK, Ciofu O, et al. Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci USA 2011;108:7481-7486.
40. Magurran AE. Species abundance distributions over time. Ecol Lett 2007;10:347-354.
41. Magurran AE, Henderson PA. Explaining the excess of rare species in natural species abundance distributions. Nature 2003;422:714-716.
42. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, Cavalcoli JD, VanDevanter DR, Murray S, Li JZ, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci USA 2012;109:5809-5814.
43. Ulrich W, Zalewski M. Abundance and co-occurrence patterns of core and satellite species of ground beetles on small lake islands. Oikos 2006;114:338-348.
44. Bjarnsholt T, Jensen PO, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB, Pressler T, Givskov M, Hoiby N. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 2009; 44:547-558.
45. Rogers GB, Carroll MP, Bruce KD. Enhancing the utility of existing antibiotics by targeting bacterial behaviour? Br J Pharmacol 2012; 165:845-857.
46. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002;109:317-325.
47. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 2006;103:8487-8492.
48. MacArthur R, Wilson E. The theory of island biogeography. Princeton: Princeton University Press; 1967.
49. Fukami T, Beaumont HJ, Zhang XX, Rainey PB. Immigration history controls diversification in experimental adaptive radiation. Nature 2007;446:436-439.
50. Edwards LJ. Modern statistical techniques for the analysis of longitudinal data in biomedical research. Pediatr Pulmonol 2000;30:330-344.
51. Kraemer R, Blum A, Schibler A, Ammann RA, Gallati S. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005;171:371-378.
52. Anderson JC, Babb AL, Hlastala MP. A fractal analysis of the radial distribution of bronchial capillaries around large airways. J Appl Physiol 2005;98:850-855.
53. Glenny RW, Bernard SL, Robertson HT. Pulmonary blood flow remains fractal down to the level of gas exchange. J Appl Physiol 2000;89:742-748.
54. West BJ. Physiology in fractal dimensions: error tolerance. Ann Biomed Eng 1990;18:135-149.
55. Kitaoka H, Suki B. Branching design of the bronchial tree based on a diameter-flow relationship. J Appl Physiol 1997;82:968-976.
56. Parker JC, Cave CB, Ardell JL, Hamm CR, Williams SG. Vascular tree structure affects lung blood flow heterogeneity simulated in three dimensions. J Appl Physiol 1997;83:1370-1382.
57. Weibel E. Design of airways and blood vessels considered as branching trees. In: Crystal RG, West JB, editors. The lung: scientific foundations. New York: Raven Press; 1991. pp. 711-720.
58. Guckenheimer J, Holmes P. Nonlinear oscillations, dynamical systems, and bifurcations of vector fields. New York: Springer-Verlag; 1983.
59. Maki D, Thompson M. Mathematical modeling and computer simulation. Pacific Grove, CA: Thomson Brooks/Cole; 2006.